WASHINGTON (AP) -- A panel of advisers to the Food and Drug Administration will consider this week whether to revoke a key indication from Abbott's blockbuster cholesterol drug Trilipix....
By MATTHEW PERRONE, Associated Press: Health
Tue, 05/17/2011 - 9:19am
WASHINGTON (AP) -- A panel of advisers to the Food and Drug Administration will consider this week whether to revoke a key indication from Abbott's blockbuster cholesterol drug Trilipix....